HOME >> MEDICINE >> NEWS
Changing prescribing behaviour through the mail

Colin Dormuth and colleagues present research in this issue of CMAJ showing the effect that a series of letters from a trusted source on evidence-based drug therapy had prescribing behaviour of physicians.

While a systematic review in The Cochrane Library concluded that printed education materials for health care professionals had negligible impact, the authors point out that effect of regular and expected printed educational materials on physician prescribing behaviour has not been studied. The study by Dormuth and colleagues determined that, while no single letter made a statistically significant difference, the overall impact of 12 letters made a big difference.

In their study of 499 physicians from 24 local health areas in British Columbia , physicians in the control group (n=241) received letters 3-8 months after physicians in the intervention group (n=258). The authors found that the probability of prescribing a drug recommended in a letter rather than another drug in the same class increased by 30% in the 3 months after that letter was mailed relative to the preceding 3 months.


'"/>

Contact: Colin Dormouth
cdormuth@hsph.harvard.edu
Canadian Medical Association Journal
25-Oct-2004


Page: 1

Related medicine news :

1. Changing chemistry helps explain estrogen threat to the heart
2. Changing trends in herbal supplement use
3. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
4. Changing the timing of cancer vaccines
5. Changing partner increases risk of preterm birth
6. Changing Life, Challenging Cancer conference
7. Changing approaches to treating gum disease
8. Changing Drug Delivery For Rheumatoid Arthritis Patients Increases Effectiveness, Lowers Costs
9. Over prescribing causing high rates of antibiotic resistance in south and east Europe
10. Pharmaceutical marketing tactics hold little sway with prescribing physicians
11. Safer drug prescribing for seniors in nursing homes: Canada leads the way

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Changing prescribing behaviour through the mail

(Date:7/28/2015)... ... July 28, 2015 , ... BMI of Texas, which specializes in a variety ... weight loss surgery procedure. Committed to helping patients achieve their weight loss goals ... Texas is one of the first practices in South Texas to offer the ...
(Date:7/28/2015)... Nashville, Tenn. (PRWEB) , ... July 28, 2015 ... ... has added the SmileCareClub Invisible Aligner System to its online product ... , By using a teledentistry model and cloud-based technology, SmileCareClub allows patients to ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Women fear developing ... reason is that cancer, heart attack, and stroke are treatable, but there is little ... can do is to take part in a clinical trial, reports the July 2015 ...
(Date:7/28/2015)... ... 28, 2015 , ... The PULs Cardiac Test™ identifies asymptomatic ... many of whom are missed by conventional evaluation , A currently unmet ... sub-clinical disease, who are at risk of experiencing a coronary event, and for ...
(Date:7/28/2015)... ... July 28, 2015 , ... For ... Top Doctors, has based its selection process on the foundation of peer nominations. ... medical specialties, in any area of medicine and in any part of the ...
Breaking Medicine News(10 mins):Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 2Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 3Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 3
(Date:7/28/2015)... -- According to a new market research report ... (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), ... published by MarketsandMarkets, the European Injectable Drug Delivery Market is ... in 2015, growing at a CAGR of 12.6% from 2015 ... market data T ables and 43 ...
(Date:7/27/2015)... July 28, 2015 CTI BioPharma Corp. (NASDAQ ... report its second quarter 2015 financial results on Thursday, ... financial markets. Following the announcement, members of the management ... the results and provide a general corporate update at ... event can be obtained as follows: Thursday, ...
(Date:7/27/2015)... DUBLIN and WESTLAKE VILLAGE, Calif. ... (NYSE: AGN ) and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: ... Trade Commission (FTC) has granted early termination of the ... 1976 (HSR Act) with respect to Allergan,s pending acquisition ... On July 6, 2015, each of ...
Breaking Medicine Technology:European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 2European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 3European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 4CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9
Cached News: